The group's principle activity is to provide wide range of product development and manufacturing services from cell line optimization and process designing to development of cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. Customers served by the group include pharmaceutical, diagnostic and biotech companies. The group’s services include upstream and downstream processing, aseptic filling or finishing, and preclinical production. The group operates from United States.
